Companion Animal Osteoarthritis Market
The companion animal osteoarthritis market consists of medical solutions for degenerative joint conditions in pets, primarily dogs and cats. The main customers are pet owners, who purchase treatments, and veterinarians, who diagnose, prescribe, and administer them. Key growth drivers include rising awareness of pet health among owners, advancements in pharmaceutical and regenerative therapies, and the increasing trend of pet humanization, which leads to higher spending on animal welfare.
CAGR
23.4%
Compound Annual Growth Rate
Current Value
$3.43B
Estimated 2026
Projected Value
$18.4B
By 2034